Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms.
Aldonza MBD, Ku J, Hong JY, Kim D, Yu SJ, Lee MS, Prayogo MC, Tan S, Kim D, Han J, Lee SK, Im SG, Ryu HS, Kim Y.
Aldonza MBD, et al.
Sci Adv. 2020 Feb 7;6(6):eaav7416. doi: 10.1126/sciadv.aav7416. eCollection 2020 Feb.
Sci Adv. 2020.
PMID: 32083171
Free PMC article.